These alterations point to an active role of CD8+ Tregs in CCA and HCC physiopathology, and future studies focusing on CD8+ Tregs levels and function, analyzing in parallel the peripheral blood, peritumoral, and tumoral tissues, may be valuable to the discovery of new biomarkers and prognostic factors of these diseases. The gene discussed is CD8A; the disease is hepatocellular carcinoma.